Experts for public labs to detect contamination
Ingredients South Asia
|December 1-15, 2025
AMIDST the increasing cases of children death linked to cough syrup contamination with the recent one in Madhya Pradesh's Chhindwara on October 31, experts have advocated that public drug testing labs should adopt advanced testing methods to detect contamination in cough syrups.
Ghaziabad based Indian Pharmacopoeia Commission (IPC) under the Union Health Ministry has also rolled out a series of hands on training workshops for public drug testing labs pan India, according to official sources.
These workshops will prominently feature training in gas chromatography (GC) for testing contamination with high levels of ethylene glycol (EG) and diethylene glycol (DEG) in medicines.
A five-month-old girl died in Madhya Pradesh's Chhindwara district allegedly after consuming Ayurvedic cough syrup. The incident comes amid the deaths of 25 children over the past two months in Chhindwara and neighbouring districts due to renal failure linked to 'Coldrif', an allopathic cough syrup found contaminated with high levels of toxic industrial solvents like ethylene glycol (EG) and diethylene glycol (DEG) in medicines.
In the Coldrif syrup case, the police have so far arrested six persons, including proprietor of the manufacturing company Sresan Pharmaceuticals, and a local paediatrician.
Close on the heels of such growing incidents, the IPC has developed a free toolkit by compiling pharmacopoeial and regulatory resources to address contamination with high levels of EG and DEG associated with liquid oral medicines, particularly in allergy, cold and cough syrups.
This document serves as a comprehensive reference, compiling key general chapters and monographs from the IP, available reference standards, along with relevant international guidances. The resources are intended to support excipients and raw material suppliers, drug manufacturers, testing laboratories, and regulatory agencies.
このストーリーは、Ingredients South Asia の December 1-15, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Ingredients South Asia からのその他のストーリー
Ingredients South Asia
With 50.40% in 2024, captive APIs led the market
PHARMACEUTICAL ingredients are mainly divided into two parts i.e. active and inactive pharmaceutical ingredients.
4 mins
December 1-15, 2025
Ingredients South Asia
As mfg evolves, quality control must adapt
IN the pharmaceutical industry, the quality of raw materials especially active pharmaceutical ingredients (APIs) and excipients is what makes medicines safe, effective and trustworthy.
4 mins
December 1-15, 2025
Ingredients South Asia
The unspoken designers of effective drug treatment
Medicine has been related to the active pharmaceutical ingredient (API), the chemical compound that produces therapeutic effect. However, the path between the discovery in a laboratory and a pill in your hand cannot be fully made without excipients.
5 mins
December 1-15, 2025
Ingredients South Asia
Adv fermentation can convert agri waste into cosmetic actives
The natural cosmetics industry is growing at an unprecedented rate. The global market is expected to grow from $52.4 billion in 2025 to $95.7 billion by 2035, which is a strong compound annual growth rate of 5.7%.
4 mins
December 1-15, 2025
Ingredients South Asia
India's cold storage leap: Driving food security
INDIA'S agriculture sector, with a GDP of $262 billion, showcases remarkable resilience, being minimally dependent on imports.
4 mins
December 1-15, 2025
Ingredients South Asia
Transforming India's ingredient mfg landscape
COME December 19-21, 2025, the pharmaceutical world will descend on Bengaluru, not just for another congress, but for a high-stakes convergence of technology, education, and industry - the 74th Indian Pharmaceutical Congress (IPC).
4 mins
December 1-15, 2025
Ingredients South Asia
in-cos attracts celebs at star-studded edition
IN-cosmetics Asia delivered its most influential edition to date. This year's event attracted a star-studded mix of high-profile industry leaders, Csuite executives, celebrity guests, Asian A-listers, beauty entrepreneurs and heads of some of the world's best-known cosmetics houses.
3 mins
December 1-15, 2025
Ingredients South Asia
CMOs optimise supply chain & reduce costs
PHARMACEUTICAL contract manufacturing is when pharmaceutical companies outsource drug production to specialised third-party manufacturers.
4 mins
December 1-15, 2025
Ingredients South Asia
Modular and compact designs are gaining traction
INDIA'S pharmaceutical sector is often referred to as the “pharmacy of the world.” Behind this reputation lies not only drug formulation expertise but also the robust ecosystem of pharma processing machinery manufacturers.
4 mins
December 1-15, 2025
Ingredients South Asia
DGFT resolves concern related to redemption of AAS
IN a significant relief for pharmaceutical exporters, the Directorate General of Foreign Trade (DGFT) has issued a clarification resolving a long-standing concern related to the redemption of Advance Authorisations (AAS) impacted by the erstwhile Rule 96(10) of the CGST Rules-2017.
2 mins
December 1-15, 2025
Listen
Translate
Change font size

